ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,281.60
-0.16%
Dow Jones
38,386.09
0.38%
Brent Oil
87.435
0.17%
Bitcoin
61,678.36
-3.38%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Inovio Pharmaceuticals Inc New (INO) Quote

Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc New (INO)

Inseego Corp
Add to Watchlist
11.50
0.93
(8.80%)
Closed April 29 4:00PM
Delayed by 15 minutes
11.50
0.00
( 0.00% )
Pre Market: 4:19AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
11.50
Bid
11.50
Ask
12.88
Volume
7
0.00 Day's Range 0.00
3.888 52 Week Range 14.748
Market Cap
268.759M
Previous Close
11.50
Open
-
Last Trade
4
@
11.5
Last Trade Time
05:24:20
Financial Volume
-
VWAP
-
Average Volume (3m)
477,413
Shares Outstanding
23,370,365
Dividend Yield
-
PE Ratio
-1.99
Earnings Per Share (EPS)
-5.78
Revenue
832k
Net Profit
-135.12M

About Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and... Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.inovio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Inovio Pharmaceuticals Inc New is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker INO. The last closing price for Inovio Pharmaceuticals was $11.50. Over the last year, Inovio Pharmaceuticals shares have traded in a share price range of $ 3.888 to $ 14.748.

Inovio Pharmaceuticals currently has 23,370,365 shares outstanding. The market capitalization of Inovio Pharmaceuticals is $268.76 million. Inovio Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.99.

INO Latest News

More News

INOVIO to Participate in Upcoming Investor Conferences in May

INOVIO to Participate in Upcoming Investor Conferences in May PR Newswire PLYMOUTH MEETING, Pa., April 29, 2024 PLYMOUTH MEETING, Pa., April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a...

23 hours ago
PR Newswire (US)

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants PR Newswire PLYMOUTH MEETING, Pa., April 15, 2024 PLYMOUTH MEETING, Pa., April...

April 15 2024
PR Newswire (US)

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine PR Newswire PLYMOUTH MEETING, Pa., March 26, 2024 PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO...

March 26 2024
PR Newswire (US)

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights PR Newswire PLYMOUTH MEETING, Pa., March 6, 2024 Announced substantial progress with lead program...

March 06 2024
PR Newswire (US)

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting PR Newswire PHILADELPHIA, March 6, 2024 PHILADELPHIA...

March 06 2024
PR Newswire (US)

U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb

U.S. index futures signal a higher opening after two days of declines, with the market focusing on the ADP survey and the Fed’s Beige Book, seeking clues about the future economy and...

March 06 2024
IH Market News

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 PR Newswire PLYMOUTH MEETING, Pa., Feb. 21, 2024 PLYMOUTH MEETING, Pa., Feb. 21, 2024 /PRNewswire/ -- INOVIO...

February 21 2024
PR Newswire (US)

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire PLYMOUTH MEETING, Pa., Feb. 7, 2024 PLYMOUTH MEETING, Pa., Feb. 7, 2024 /PRNewswire/ -- INOVIO...

February 07 2024
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Feb. 2, 2024 PLYMOUTH MEETING, Pa., Feb. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

February 02 2024
PR Newswire (US)

Form EFFECT - Notice of Effectiveness

February 01 2024
Edgar (US Regulatory)

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYCCCyclacel Pharmaceuticals Inc
$ 2.68
(97.06%)
1.64M
WGSGeneDx Holdings Corporation
$ 14.33
(30.27%)
90.05k
MRINMarin Software Incorporated
$ 3.37
(29.12%)
320.05k
MLECMoolec Science SA
$ 1.76
(28.47%)
72.31k
STSSSharps Technology Inc
$ 0.318
(23.59%)
100
LICNLichen China Limited
$ 1.56
(-23.15%)
173.56k
EGOXNext e GO NV
$ 0.023
(-16.67%)
1.26M
ICLKiClick Interactive Asia Group Ltd
$ 1.00
(-15.25%)
330
BSGMBioSig Technologies Inc
$ 1.16
(-13.43%)
2.18k
ILAGIntelligent Living Application Group Inc
$ 0.65
(-13.01%)
11.64k
GWAVGreenwave Technology Solutions Inc
$ 0.0792
(21.85%)
20.05M
JAGXJaguar Health Inc
$ 0.234
(12.50%)
3.93M
FFIEFaraday Future Intelligent Electric Inc
$ 0.043
(2.87%)
2.33M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.93
(-4.59%)
1.65M
CYCCCyclacel Pharmaceuticals Inc
$ 2.68
(97.06%)
1.64M

INO Discussion

View Posts
harry crumb harry crumb 6 days ago
Yep
👍️0
MiamiGent MiamiGent 2 weeks ago
Yup, same old Inovio story- Reverse Split and Dilute.

One of the most disreputable stocks, ever.

MG
Father of The Inovio Scam Expose
👍️0
AMA AMA 2 weeks ago
https://finance.yahoo.com/news/inovio-announces-pricing-approximately-36-223900148.html
👍️0
axelvento axelvento 3 weeks ago
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
https://www.nature.com/articles/s41591-024-02894-y
👍️0
trunkmonk trunkmonk 3 weeks ago
bolly is folly, dont worry about them, dey completely historical data. its ok to look at them with many other things, but they predict nothing forward as far as direction nor direction, they are just dust off a comet.
👍️0
MiamiGent MiamiGent 4 weeks ago
You are confused. .06 IS the value of a share of INO today, when the three most recent Reverse Splits to INO are accounted for.

INO is worth 6.2 cents at tonight's close of $11.95, accounting for the three most recent splits.

Inovio is one of the longest running scams in the history of the stock market.

Forty-Seven (47) years- not one approved drug, therapy or vaccine originated.

Be careful to not post inaccurate messages that could prompt newbees to lose their hard-earned money on this penny stock.


MG
Father of The Inovio Scam Expose
👍️ 1
smoking guns smoking guns 4 weeks ago
.06 to some,$13.01 to buy in now.
👍️0
MiamiGent MiamiGent 1 month ago
INO Touting INO, to suck in unsuspecting newbees, is a bad look.
Just taking the most recent three (3) Reverse Splits, a share of INO at tonight's close of $13.03 is worth .06 cents.

Six cents. Only one lacking an active conscience would pump "no product originated in its 47 years" Inovio.

MG
Father of The Inovio Scam Expose
👍️0
smoking guns smoking guns 1 month ago
Will the gentleman from MIami please acknowledge the $13.01 PPS at today's close.Thank you in advance. SG
👍️0
smoking guns smoking guns 1 month ago
INO PPS $12.51 EOD. Wonder what the weather is in Miami right now ??
👍️0
smoking guns smoking guns 1 month ago
Well, there it is a $12.40 PPS close. Awful quiet on the negative front.
👍️0
smoking guns smoking guns 1 month ago
Headed for another great close again today !!
👍️0
smoking guns smoking guns 1 month ago
Another great close ....$11.62
👍️0
smoking guns smoking guns 1 month ago
Must be killing the bashers to see INO up and holding between $10.& $12.
👍️0
radly radly 3 months ago
This good for nothing company will be back below a $1 in no time!
👍️0
philaya philaya 3 months ago
global cash day...
all cash,got lucky.
👍️0
gew59 gew59 3 months ago
Wow - down 15% after the reverse.
👍️0
MiamiGent MiamiGent 3 months ago
So, let's see. INO is valued at three and a half cents, today, when the two most recent Reverse Splits are accounted for. So with this new Split, whatever the SP briefly pops to will have to be divided by a further twelve.
I bet the SP ends up a subbie, below a penny.

When you think of all the unconscionable pumpers that pushed Inovio, including one saying INO was even more valuable than Google, it really disgusts.

So many mostly young, poor, hopeful 'nubes wiped out with this scam.

MG
Father of The Inovio Scam Expose
👍️ 1
gew59 gew59 3 months ago
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split

https://ir.inovio.com/news-releases/news-releases-details/2024/INOVIO-Announces-Effective-Date-of-1-for-12-Reverse-Stock-Split/default.aspx
👍️0
philaya philaya 4 months ago
Yemen...
All out,got lucky.
👍️0
philaya philaya 4 months ago
All out ..
Market unload day.
👍️0
philaya philaya 4 months ago
Added more ...
Uptrend not slowing.
👍️0
philaya philaya 4 months ago
sold some...
dip tactics.
👍️0
philaya philaya 4 months ago
Bears gone...
9uppy day.
👍️0
MiamiGent MiamiGent 4 months ago
I don't know if my calculator can go much lower than INO's current share price, gew59?

It's 2.4 cents at tonight's close, when the two most recent R/S's are accounted for.

I suppose I could consult a University's Calculus Dept to compute Inovio's continued share price declines.


MG
Father of The Inovio Scam Expose
👍️0
gew59 gew59 4 months ago
About time for another reverse. Get your calculator ready - lol.
👍️0
philaya philaya 4 months ago
All not gone ..
Some good coming.
👍️0
philaya philaya 4 months ago
got some...
all good.
👍️0
MiamiGent MiamiGent 4 months ago
INO now worth 2.5 cents, when the two most recent R/S's accounted for.

What a POS!
👍️0
philaya philaya 5 months ago
all out...
go to alt.
👍️0
philaya philaya 5 months ago
up now...
who cares.
👍️0
MiamiGent MiamiGent 5 months ago
Because it's a POS stock. A long running scam.
Mr Inovio everything (founder, president, ceo and director & chairman until 2019) Avtar Dhillon is been facing stock fraud charges in Massachusetts.
CEO Kim and the Scottish women have taken off.
Inovio has not accomplished a single drug, therapy or vaccine in it's entire 47 years. Zero. And suckered investors for about 1B

Stay away from INO- It's a Scam and always has been since it started as a penny stock promoted by Dhillon.

The most recent two Reverse Splits were both 1 for 4. So, divide the current SP by 4, and then 4 again.
A few cents. That's what the market thinks of this penny stock scam.

MG
Father of The Inovio Scam Expose
No position in about twelve years
Was no burnt by INO
👍️0
philaya philaya 5 months ago
Mcap 100m...
So low,unreal.
👍️0
philaya philaya 5 months ago
all in now...
some burgers money.
👍️0
philaya philaya 5 months ago
sold and buy back smaller bet...
mostly in aaoi.
👍️0
smoking guns smoking guns 5 months ago
"INO "possible 1-10 R/Split would help finance the Co.to move forward on their promising programs . A buy in at these prices may be smart and worth it for the near future and beyond.
👍️0
philaya philaya 5 months ago
back in...
looking easy.
👍️0
Monksdream Monksdream 6 months ago
INO new 52 week low
👍️0
philaya philaya 6 months ago
got some...
doing debts reduction btw.
👍️0
MiamiGent MiamiGent 6 months ago
You for apparently still pushing this scam and it's discarded zapper.

I gather you lost big on this scam
👍️0
MiamiGent MiamiGent 6 months ago
INO Inovio Pharmaceuticals Inc $0.392

When two most recent Inovio Reverse Splits are accounted for, an INO share is worth .0245 at last nights close

Inovio .... two cents

Some Investors at $35 in 2020 have had their financial lives ruined, for years to come.


MG
Father of The Inovio Scam Expose
👍️0
doc2016 doc2016 6 months ago
considerations on how to talk to your dna? i've read novocure ttf has effect on tubulin/ microtubules. inovio could create new synthetic dna and proteins and such molecules which can effect cellular function and production. msft can sequence dna/proteins. Crispr can cut out the bad dna. replace the bad dna with the good products of same dna but good form,, or enable off to be on or vice versa? quantum stuff. memristive quantum stuff? production of dna to protein production is an application? along the way there is communications or waypoints where functionality is expressed. potentially, neoantigens or other biomarkers which can be detected and used to early know/diagnose a problem. like routine maintenance checks. and corrective action taken to mitigate or terminate the badness/development of badness?
👍️0
AMA AMA 6 months ago
INO....BLA FROM THE FDA
https://www.prnewswire.com/news-releases/inovio-receives-fda-feedback-that-data-from-completed-phase-12-trial-of-ino-3107-can-be-used-to-submit-a-bla-under-accelerated-approval-program-301951543.html
👍️0
philaya philaya 6 months ago
Now all in ...
Much buying.
👍️0
philaya philaya 7 months ago
all out...
tpst better.
👍️0
philaya philaya 7 months ago
very nice...
looking good.
👍️0
kampman kampman 7 months ago
Who is discredited now. That zapper is saving lives while making me rich. Goofball. Why haven't you been spouting of the last several days?
👍️ 1
Invest-in-America Invest-in-America 7 months ago
And now it WENT.
👍️0
Triple nickle Triple nickle 7 months ago
There it goes
👍️0
europtiger europtiger 7 months ago
Now going
👍️0

Your Recent History

NASDAQ
INO
Inovio Pharmaceuticals
NASDAQ
SINT
SiNtx Technologies
NASDAQ
MULN
Mullen Automotive
NASDAQ
SQQQ
ProShares UltraPro Short...
NASDAQ
PEGY
Pineapple Energy
NASDAQ
TSLA
Tesla
NASDAQ
TSLL
Direxion Daily TSLA Bull...
NASDAQ
FFIE
Faraday Future Intellige...
NASDAQ
ZAPP
Zapp Electric Vehicles
NASDAQ
CLOU
Global X Cloud Computing...
NASDAQ
XELA
Exela Technologies
NASDAQ
EGOX
Next e GO NV
NASDAQ
MDIA
Mediaco
NASDAQ
OLB
OLB
NASDAQ
ILAG
Intelligent Living Appli...
NASDAQ
BSGM
BioSig Technologies
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved